Prioritizing Life-Saving Point-of-Care (POC) Diagnostics in the Aftermath of an Outbreak. Global Health Mini University March 4, 2016

Size: px
Start display at page:

Download "Prioritizing Life-Saving Point-of-Care (POC) Diagnostics in the Aftermath of an Outbreak. Global Health Mini University March 4, 2016"

Transcription

1 Prioritizing Life-Saving Point-of-Care (POC) Diagnostics in the Aftermath of an Outbreak Global Health Mini University March 4, 2016

2 The following materials are based upon personal experiences working as part of an Ebola emergency response team Nov 2014 Feb The information presented herein does not imply the expression of any opinion whatsoever on the part of any governmental, non-governmental or multilateral entity.

3 Ebola Outbreak Response SIERRA LEONE NOV 26, 2014

4 Source: WHO Ebola Response Roadmap Situation Report 26 November 2014 retrieved 2 February 2016 from:

5 Source: WHO Ebola Response Roadmap Situation Report 26 November 2014 retrieved 2 February 2016 from:

6 Source: WHO Ebola Response Roadmap Situation Report 26 November 2014 retrieved 2 February 2016 from:

7 Community Care Center (CCC) Established at source by local chief Early patient isolation Isolation within local community Sickest patients transferred for higher level care Considerations Staffing Training PPE Diagnostics

8 Diagnostics Reliable and rapid diagnostics are critical during an outbreak Point of care (POC) tests Molecular laboratory-based tests Special considerations Regulatory requirements Biosafety Quality of users and sites Finance and investment

9 Your Mission You will have been given a character as you entered the room: Student nurse Patient Phlebotomist / Laboratory Technologist In your role consider the following: What are the challenges of working in an outbreak situation? How does the challenges impact patient care? How can the quality of diagnostic testing can be improved? What are the advantages and disadvantages of POC vs molecular testing?

10 CCC INTERACTIVE STATIONS

11 CCC, Scenario: Molecular testing of suspected Ebola sample Draw blood via venipuncture from a suspected Ebola patient Package sample for shipment to a reference laboratory for molecular testing

12 CCC, Scenario: Point of Care Testing Rapid Diagnostic Testing of suspected Ebola sample Draw blood via fingerpick from a suspected Ebola patient Perform Point-of-Care (POC) Diagnostics

13 Activities DONNING, PHLEBOTOMY, TESTING & SAMPLE REFERRAL

14 Donning PPE Note that this session focuses on diagnostic challenges during an emergency outbreak situation We do not have time to demonstrate proper donning and doffing! We have 3 sets of PPE, 1 for each of the following staff: Triage nurse Nurse Phlebotomist GSSHealth team members will assist you to put on your PPE Note that the supplies we are using are identical to supplies used in the field.

15 Phlebotomy Note: Highly trained phlebotomists were in short supply and in particular need as cases climbed. Appropriate blood collection supplies were not always available. Group 1 will collect samples using a finger-stick (finger-prick) technique Group 2 will collect samples via venipuncture GSSHealth team members will assist you to perform sample collection *Note that we not collecting human samples and are using colored dye as fake blood!*

16 Testing and Sample Referral Note: a true point of care test was not available at the time of CCC scale-up. POC tests for Ebola are still under development. Group 1 will use a rapid diagnostic test (RDT) in the CCC Group 2 will package the blood sample for shipment to another laboratory for molecular testing GSSHealth team members will assist you to perform these tasks

17 DISCUSSION

18 Discussion Points: Sample Collection What challenges did staff face when collecting the sample? What safety issues exist when collection samples in this setting? Public domain copyright: CDC. (2011). Retrieved from: Public domain copyright: CDC. Retrieved from:

19 Discussion Points: Sample Testing Did you find it easy to perform the test? What external factors could have influenced your test results? What safety issues exist when performing tests in this setting? From ReEBOVTM Antigen Rapid Test (Ebolavirus VP40 Antigen Detection) Instructions for Use ftp://ftp.corgenix.com/intra/reebov/14005.pdf

20 Discussion Points: Result Interpretation Was it easy to understand the instructions on how to interpret results? Where the test results clear? Were you able to easily interpret your test results? From ReEBOVTM Antigen Rapid Test (Ebolavirus VP40 Antigen Detection) Instructions for Use ftp://ftp.corgenix.com/intra/reebov/14005.pdf

21 CONCLUSIONS

22 Conclusion POC diagnostic testing during infectious disease outbreaks can greatly improve the time to diagnosis Quality of POC tests and entire process is critical to ensure that patients are diagnosed quickly and accurately, for proper care and treatment Proper PPE must be procured and used Regulatory processes for new POC tests much be established to ensure they are safe, effective, affordable and appropriate for the outbreak R&D plays an important role in development of new POC diagnostics

Selection and use of Ebola in vitro diagnostic (IVD) assays

Selection and use of Ebola in vitro diagnostic (IVD) assays EMERGENCY GUIDANCE Selection and use of Ebola in vitro diagnostic (IVD) assays June 2015 World Health Organization 2015. All rights reserved. The designations employed and the presentation of the material

More information

Surveillance strategy during Phase 3 of the Ebola response

Surveillance strategy during Phase 3 of the Ebola response EMERGENCY GUIDANCE Surveillance strategy during Phase 3 of the Ebola response 5 November 2015 World Health Organization 2015. All rights reserved. The designations employed and the presentation of the

More information

Interfacility Transport of a Patient with

Interfacility Transport of a Patient with Interfacility Transport of a Patient with Functional Exercise After-Action Report/Improvement Plan After-Action Report/ aligns exercise objectives with preparedness doctrine to include the National Preparedness

More information

Chicago Ebola Preparedness Update. Suzet McKinney, DrPH, MPH, Deputy Commissioner Stephanie Black, MD, MSc, Medical Director March 18, 2015

Chicago Ebola Preparedness Update. Suzet McKinney, DrPH, MPH, Deputy Commissioner Stephanie Black, MD, MSc, Medical Director March 18, 2015 Chicago Ebola Preparedness Update Suzet McKinney, DrPH, MPH, Deputy Commissioner Stephanie Black, MD, MSc, Medical Director March 18, 2015 Agenda Ebola Overview Crisis in West Africa Symptoms and transmission

More information

CDC Support for Exit Screening and Lessons Learned for Preparedness

CDC Support for Exit Screening and Lessons Learned for Preparedness CDC Support for Exit Screening and Lessons Learned for Preparedness Andrew Demma, MS International Assistance Lead Global Migration Task Force Centers for Disease Control and Prevention National Center

More information

(Public Health) Management of Ebola Disease. Aura Timen, MD, PhD. National Coordination Centre for Communicable Disease Control (LCI) CIb

(Public Health) Management of Ebola Disease. Aura Timen, MD, PhD. National Coordination Centre for Communicable Disease Control (LCI) CIb (Public Health) Management of Ebola Disease Aura Timen, MD, PhD National Coordination Centre for Communicable Disease Control (LCI) CIb Het hoe,wat en wie van de LCI Everybody knows that pestilences have

More information

Rapid Diagnostic Tests in Microbiology (PAs & PHs) I.Afeke UHAS

Rapid Diagnostic Tests in Microbiology (PAs & PHs) I.Afeke UHAS Rapid Diagnostic Tests in Microbiology (PAs & PHs) I.Afeke UHAS Positive Negative Objective: Upon completion of this topic, the student should be able to: What a rapid diagnostic test (RDT) is When a RDT

More information

Preparations for Ebola Vaccine Deployment

Preparations for Ebola Vaccine Deployment Preparations for Ebola Vaccine Deployment Ebola vaccine and vaccination - Session 8 Meeting of the Strategic Advisory Group of Experts on Immunization (SAGE) Geneva, 14 16 April 2015 Dr Marie-Pierre Preziosi,

More information

Firms and Federal Labs Flock to Seek FDA Emergency Use Authorization for Ebola MDx Assays

Firms and Federal Labs Flock to Seek FDA Emergency Use Authorization for Ebola MDx Assays Firms and Federal Labs Flock to Seek FDA Emergency Use Authorization for Ebola MDx Assays October 21, 2014 Firms and Federal Labs Flock to Seek FDA Emergency Use Authorization for Ebola MDx Assays By Madeleine

More information

Global response plan for pfhrp2/3 deletions

Global response plan for pfhrp2/3 deletions Global response plan for pfhrp2/3 deletions Jane Cunningham MPAC 17-19 October, 2017 The global response plan for pfhrp2/3 mutations that limit the effectiveness of HRP2- based RDTs comprises a global

More information

Clinical validation trial of a diagnostic for Ebola Zaire antigen detection: Design rationale and challenges to implementation

Clinical validation trial of a diagnostic for Ebola Zaire antigen detection: Design rationale and challenges to implementation Design Clinical validation trial of a diagnostic for Ebola Zaire antigen detection: Design rationale and challenges to implementation CLINICAL TRIALS Clinical Trials 2016, Vol. 13(1) 66 72 Ó The Author(s)

More information

Interim Technical Note The Use of Cholera Rapid Diagnostic Tests November 2016

Interim Technical Note The Use of Cholera Rapid Diagnostic Tests November 2016 Objective Interim Technical Note The Use of Cholera Rapid Diagnostic Tests November 2016 To provide interim guidance to Ministries of Health and other organizations on the potential use of commercially

More information

Ebola by the Numbers: Not a Small-scale Killer Anymore

Ebola by the Numbers: Not a Small-scale Killer Anymore Ebola by the Numbers: Not a Small-scale Killer Anymore Ebola in West Africa Previously confined to Central African countries Emerged in Guinea at end of 2013 Source: Feldmann & Geisbert, Lancet 2011 Two

More information

Diagnostics: Learning from successful experiences which made it to market. Mark Miller, MD Chief Medical Officer biomérieux France

Diagnostics: Learning from successful experiences which made it to market. Mark Miller, MD Chief Medical Officer biomérieux France Diagnostics: Learning from successful experiences which made it to market Mark Miller, MD Chief Medical Officer biomérieux France Diagnostics: Learning from unsuccessful experiences which almost made it

More information

ReEBOV Antigen Rapid Test kit for point-of-care and laboratory-based testing for Ebola virus disease: a field validation study

ReEBOV Antigen Rapid Test kit for point-of-care and laboratory-based testing for Ebola virus disease: a field validation study ReEBOV Antigen Rapid Test kit for point-of-care and laboratory-based testing for Ebola virus disease: a field validation study Mara Jana Broadhurst, John Daniel Kelly, Ann Miller, Amanda Semper, Daniel

More information

A surveillance of Ebola outbreak at Télimélé, Guinea Conakry 2014

A surveillance of Ebola outbreak at Télimélé, Guinea Conakry 2014 A surveillance of Ebola outbreak at Télimélé, Guinea Conakry 2014 Jean Marie Vianney Namahoro Postgraduate student Stellenbosch University Fakulteit Geneeskunde en Gesondheidswetenskappe Faculty of Medicine

More information

Maine Ebola Response Plan. Jane Coolidge PhD, RN DHHS, Maine CDC, PHEP

Maine Ebola Response Plan. Jane Coolidge PhD, RN DHHS, Maine CDC, PHEP Maine Ebola Response Plan Jane Coolidge PhD, RN DHHS, Maine CDC, PHEP Ebola 2014 2014 the world experienced the largest Ebola outbreak in history affecting the West African countries of Sierra Leone, Liberia,

More information

Intersection of LEAN and the LIS. Megan Schmidt. Product Manager, Sunquest Information Systems, Inc. Patrick O Sullivan

Intersection of LEAN and the LIS. Megan Schmidt. Product Manager, Sunquest Information Systems, Inc. Patrick O Sullivan Intersection of LEAN and the LIS Megan Schmidt Product Manager, Sunquest Information Systems, Inc. Patrick O Sullivan Laboratory Director, Florida Hospital Orlando Agenda Manufacturing Mindset LEAN Principles

More information

Guidance Note H1402 Packaging and Transport of waste from suspect

Guidance Note H1402 Packaging and Transport of waste from suspect uid Guidance Note H1402 Packaging and Transport of waste from suspect and confirmed cases of the Ebola Virus Revision: 1.0 Date: 21/10/2014 Contents 1 Purpose... 3 2 Introduction... 3 3 Regulations...

More information

EBOLA AND PREPAREDNESS AT DENVER HEALTH. Amber Miller, MSN, RN, CIC, CSPDT, Infection Prevention Manager Denver Health

EBOLA AND PREPAREDNESS AT DENVER HEALTH. Amber Miller, MSN, RN, CIC, CSPDT, Infection Prevention Manager Denver Health EBOLA AND PREPAREDNESS AT DENVER HEALTH Amber Miller, MSN, RN, CIC, CSPDT, Infection Prevention Manager Denver Health Denver Health and Hospital September 18, 2015 Agenda Background on Ebola Overview of

More information

Standard Project Report 2015

Standard Project Report 2015 Standard Project Report 2015 Reporting Period: 1 January - 31 December 2015 WEST AFRICA (DAKAR) Logistics Common Services for the Humanitarian Community's Response to the Ebola Virus Disease Outbreak in

More information

EBOLA RESPONSE ROADMAP ROADMAP SITUATION REPORT

EBOLA RESPONSE ROADMAP ROADMAP SITUATION REPORT HIGHLIGHTS EBOLA RESPONSE ROADMAP ROADMAP SITUATION REPORT SITUATION REPORT 3 DECEMBER 2014 There have been 17 145 reported cases of Ebola virus disease (EVD), with 6070 reported deaths. Case incidence

More information

New Tools for the Enhanced

New Tools for the Enhanced New Tools for the Enhanced Management of Chronic Disease Based on a Proprietary, Point of Care, Electrochemical Detection System Universal Biosensors Investor Presentation February 2010 1 Important disclaimer

More information

Aligning Process Redesign and Change Management with Project Management (System Implementation Projects)

Aligning Process Redesign and Change Management with Project Management (System Implementation Projects) Aligning Redesign and Change Management with Project Management (System Implementation Projects) Kim Brant-Lucich Director of Redesign St. Joseph Health System Information Services HIMSS 2009: Project

More information

Visualize This! Meaningful Metrics for Managing Risk

Visualize This! Meaningful Metrics for Managing Risk Visualize This! Meaningful Metrics for Managing Risk SESSION ID: GRC-F02 Moderator: Panelists: John Johnson Global Security Strategist John Deere Alex Hutton Director of Operations Risk & Governance A

More information

Ebola Zaire Real-TM Handbook

Ebola Zaire Real-TM Handbook For Professional Use Only Ebola Zaire Real-TM Handbook Real-Time PCR test for qualitative detection of Ebola Virus 100 REF V69-100FRT NAME Ebola Zaire Real-TM INTRODUCTION Ebola virus (EBOV, formerly designated

More information

Practical Applications of Immunology (Chapter 18) Lecture Materials for Amy Warenda Czura, Ph.D. Suffolk County Community College Eastern Campus

Practical Applications of Immunology (Chapter 18) Lecture Materials for Amy Warenda Czura, Ph.D. Suffolk County Community College Eastern Campus Practical Applications of Immunology (Chapter 18) Lecture Materials for Amy Warenda Czura, Ph.D. Suffolk County Community College Eastern Campus Primary Source for figures and content: Tortora, G.J. Microbiology

More information

Recommended Good Laboratory Practices Waived Testing Sites Overview Considerations Before Introducing Waived Testing or Offering a New Waived Test

Recommended Good Laboratory Practices Waived Testing Sites Overview Considerations Before Introducing Waived Testing or Offering a New Waived Test Recommended Good Laboratory Practices Waived Testing Sites Overview These recommendations are intended to promote the use of good laboratory practices by physicians, nurses, and other providers of waived

More information

Privacy in Ethics and Ebola: Public Health Planning and Response

Privacy in Ethics and Ebola: Public Health Planning and Response Privacy in Ethics and Ebola: Public Health Planning and Response Contents I. Introduction... 1 III. Background... 2 A. Privacy and the Collection, Use, and Sharing of Ebola Biospecimens for Research2 B.

More information

WFP West Africa Regional Bureau REGIONAL SPECIAL OPERATION SO

WFP West Africa Regional Bureau REGIONAL SPECIAL OPERATION SO WFP West Africa Regional Bureau REGIONAL SPECIAL OPERATION SO 200773 Country: West Africa Regional Bureau (OMD) Ghana, Guinea, Sierra Leone, and Liberia Type of project: Special Operation Title: Logistics

More information

Announcements. Please mute your phones and DO NOT place us on hold. Press *6 to mute/unmute your phone.

Announcements. Please mute your phones and DO NOT place us on hold. Press *6 to mute/unmute your phone. 1 Announcements Register for the Epi-Tech Trainings: 1. Log-on or Request log-on ID/password: https://tiny.army.mil/r/zb8a/cme 2. Register for Epi-Tech Surveillance Training: https://tiny.army.mil/r/leaid/epitechfy15

More information

Scenario planning and uncertainty

Scenario planning and uncertainty Scenario planning and uncertainty Developing a dynamic strategy in a changing healthcare environment kpmg.com Several trends in the US healthcare industry are poised to change the nature of the provider

More information

Assessing quality-assured diagnoses made by TB laboratories

Assessing quality-assured diagnoses made by TB laboratories Assessing quality-assured diagnoses made by TB laboratories Quality-assured TB laboratory Objectives: at the end of the assessment reviewers should comment on the laboratory network and its structure;

More information

Step-by-Step Description of ELISA

Step-by-Step Description of ELISA Step-by-Step Description of ELISA The protocols in this kit rely on indirect antibody capture ELISA. The steps in this assay are: Step 1: Antigen is added to the wells of the microplate strip and incubated

More information

EBOLA SITUATION REPORT

EBOLA SITUATION REPORT EBOLA SITUATION REPORT 30 MARCH 2016 SUMMARY The International Health Regulations (2005) Emergency Committee regarding Ebola virus disease (EVD) in West Africa met for a ninth time on 29 March. On the

More information

Public private partnerships

Public private partnerships THE INTERNATIONAL CONFERENCE ON (RE-)EMERGING INFECTIOUS DISEASES 14 March 2018 in Addis Ababa, Ethiopia Public private partnerships Engaging the private research sector to scale up infectious diseases

More information

Ebola Q & A. # Question Answer Modified

Ebola Q & A. # Question Answer Modified Ebola Q & A # Question Answer Modified 1 Are U.S. hospitals ready to care for patients with Ebola virus disease (EVD)? Yes any U.S. hospital that is following CDC's infection control recommendations(http://www.cdc.gov/vhf/ebola/hcp/infectionprevention-and-control-recommendations.html)

More information

ICT contributions and challenges for logistics innovation Zaragoza, 25 th of October 2013

ICT contributions and challenges for logistics innovation Zaragoza, 25 th of October 2013 ICT contributions and challenges for logistics innovation Zaragoza, 25 th of October 2013 ECITL Parallel B (Friday 12:30): ICT contributions and challenges for logistics innovation Moderators: Georgia

More information

ADAPTIVE BIOTECHNOLOGIES DIAGNOSTIC PORTAL: ACCOUNT LOGIN

ADAPTIVE BIOTECHNOLOGIES DIAGNOSTIC PORTAL: ACCOUNT LOGIN ADAPTIVE BIOTECHNOLOGIES DIAGNOSTIC PORTAL: ACCOUNT LOGIN 1. Create an account. To set up your account for our online order entry and reporting system, please go to: https://diagnostics.adaptivebiotech.com/account/login.

More information

2014 APHL Next Generation Sequencing (NGS) Survey

2014 APHL Next Generation Sequencing (NGS) Survey APHL would like you to complete the Next Generation Sequencing (NGS) in Public Health Laboratories Survey. The purpose of this survey is to collect information on current capacities for NGS testing and

More information

R&D for potential vaccines for the Ebola virus

R&D for potential vaccines for the Ebola virus R&D for potential vaccines for the Ebola virus Update 4 March 2015 Roberto Bertollini MD MPH Chief Scientist and WHO Representative to the EU Gathering knowledge Since August 2014, series of consultations

More information

BIOSAFETY AND BIOSECURITY (BSS) Series Catalog

BIOSAFETY AND BIOSECURITY (BSS) Series Catalog BIOSAFETY AND BIOSECURITY (BSS) Series Catalog CITI Program s BSS series consists of courses that cover a variety of biosafety and biosecurity topics. These courses address basic information for multiple

More information

INAUGURAL LABORATORY NEWSLETTER

INAUGURAL LABORATORY NEWSLETTER New Mexico Department of Health Scientific Laboratory Division News Fall/Winter 2008 INAUGURAL LABORATORY NEWSLETTER From the Director David Mills, Ph.D., HCLD SLD Director I would like to take this opportunity

More information

Obtain a set of DNA sequences that includes the reference sample from Guinea and 15 Ebola DNA sequences from samples of patients in Sierra Leone.

Obtain a set of DNA sequences that includes the reference sample from Guinea and 15 Ebola DNA sequences from samples of patients in Sierra Leone. INTRODUCTION In this activity, you will analyze sequences of Ebola viruses isolated from patients in Sierra Leone during the Ebola outbreak of 2013 2016 to track the virus spread. Do you have what it takes

More information

How Information Transformation Drives Healthcare Performance

How Information Transformation Drives Healthcare Performance perspective How Information Transformation Drives Healthcare Performance Abstract Healthcare delivery in the US is experiencing tectonic change and has rapidly moved towards a Consumer-centric, market-driven

More information

Classroom Discussion Guide on Ethics and Public Health Emergencies

Classroom Discussion Guide on Ethics and Public Health Emergencies Classroom Discussion Guide on Ethics and Public Health Emergencies This guide provides discussion questions and topics based on the Presidential Commission for the Study of Bioethical Issues report, Ethics

More information

Diagnostics gathering intelligence to fight antimicrobial resistance

Diagnostics gathering intelligence to fight antimicrobial resistance Diagnostics gathering intelligence to fight antimicrobial resistance Arjon van Hengel European Commission DG Research and Innovation, Health Directorate Unit "Fighting Infectious Diseases and Advancing

More information

Biomedical Waste Handling and Disposal

Biomedical Waste Handling and Disposal Approved by: Biomedical Waste Handling and Disposal Corporate Director, Environmental Supports Environmental Services Operating Standards Manual Number: Date Approved Next Review May 3, 2018 Purpose Applicability

More information

Continuity of Operations Planning: Responding to. Provide Critical Services

Continuity of Operations Planning: Responding to. Provide Critical Services Continuity of Operations Planning: Responding to Emergencies While Continuing to Provide Critical Services Business Continuity Planning Ali Jaffe-Doty Public Health - Seattle & King County Session Objectives

More information

Liquid culture Practical challenges with MGIT

Liquid culture Practical challenges with MGIT Reality check! Ensuring the pertinence of TB diagnostic tools for the peripheral l level Médecins Sans Frontières res Satellite IUATLD Conference,, Palais des Congrès, PARIS Sunday 19th October 2008 Liquid

More information

EBOLA RESPONSE ROADMAP

EBOLA RESPONSE ROADMAP EBOLA RESPONSE ROADMAP World Health Organization 2014 All rights reserved. Publications of the World Health Organization are available on the WHO website (www.who.int) or can be purchased from WHO Press,

More information

Simplify processess Increase revenue Reach your MU goals

Simplify processess Increase revenue Reach your MU goals NextGen Professional Consulting Services Simplify processess Increase revenue Reach your MU goals Running a medical practice isn t easy. With daily responsibilities of patient care, managing staff, and

More information

An Investigation into the Existing Capacity and Screening Procedures for Ebola at Jomo Kenyatta International Airport, Nairobi

An Investigation into the Existing Capacity and Screening Procedures for Ebola at Jomo Kenyatta International Airport, Nairobi 2016 IJSRSET Volume 2 Issue 4 Print ISSN : 2395-1990 Online ISSN : 2394-4099 Themed Section: Science and Technology An Investigation into the Existing Capacity and Screening Procedures for Ebola at Jomo

More information

SHIPPING. 1.2 Infectious Substance: Substances which are known or are reasonably expected to contain pathogens

SHIPPING. 1.2 Infectious Substance: Substances which are known or are reasonably expected to contain pathogens Page 1 of 6 The International Air Transport Association (IATA) and US Department of Transportation (DOT) have regulations regarding shipments containing Dangerous Goods, which are defined as articles or

More information

UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES

UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES Biodefense solutions to protect our nation Forward genomic surveillance advances DoD biomedical research toward combating high-consequence

More information

Molecular Diagnostics for Global Heath Problems. Proactive Investors Forum 5 October 2017

Molecular Diagnostics for Global Heath Problems. Proactive Investors Forum 5 October 2017 Molecular Diagnostics for Global Heath Problems Proactive Investors Forum 5 October 2017 2 Document Information The information contained in this document and made verbally to you (together the Presentation

More information

Strengthening Laboratory Management Toward Accreditation. Module 7: Specimen Collection and Processing

Strengthening Laboratory Management Toward Accreditation. Module 7: Specimen Collection and Processing Strengthening Laboratory Management Toward Accreditation Module 7: Specimen Collection and Processing My Lab Collects & Cares for patients specimens properly 2 Key Message My lab collects and cares for

More information

Impedance Analysis and Antibody Immobilization to Differentiate Methicillin- Resistant Staphylococcus Aureus

Impedance Analysis and Antibody Immobilization to Differentiate Methicillin- Resistant Staphylococcus Aureus Impedance Analysis and Antibody Immobilization to Differentiate Methicillin- Resistant Staphylococcus Aureus Kaitlyn Tingley 1, Amanda Bukhtia 1, Yawen Li 2, Mansoor Nasir 2, Therese Bou-Akl 2, Dr. Gregory

More information

DISASTER A total of 2,615 Ebola infections and 1,427 deaths highest case fatality rates of any human virus, 88%

DISASTER A total of 2,615 Ebola infections and 1,427 deaths highest case fatality rates of any human virus, 88% DISASTER A total of 2,615 Ebola infections and 1,427 deaths highest case fatality rates of any human virus, 88% ETYMOLOGY First recorded outbreak at,yambuku in democratic republic of congo (EBOLA RIVER)

More information

Leveraging Internal Audit and Corporate Compliance for Effective Risk Management

Leveraging Internal Audit and Corporate Compliance for Effective Risk Management Leveraging Internal Audit and Corporate Compliance for Effective Risk Management April 18, 2016 Don Sinko Chief Integrity Officer Cleveland Clinic Agenda Cleveland Clinic Integrity Office Model The 3 Lines

More information

COMMUNITY SERVICE WORKER 1 COMMUNITY SERVICE WORKER 2

COMMUNITY SERVICE WORKER 1 COMMUNITY SERVICE WORKER 2 B001 B002 Established 01-30-91 COMMUNITY SERVICE WORKER 1 COMMUNITY SERVICE WORKER 2 DEFINITION To provide a variety of services to the community and to assist departments in accomplishing their missions;

More information

Ebola Facts. October 14, 2014

Ebola Facts. October 14, 2014 Ebola Facts October 14, 2014 Symptoms of Ebola Initial symptoms are nonspecific - may include fever, chills, myalgias, and malaise. Patients can progress to develop gastrointestinal symptoms: severe watery

More information

16S rdna Sequencing Diagnosis of Spirochetemia in Lyme and related Borrelioses

16S rdna Sequencing Diagnosis of Spirochetemia in Lyme and related Borrelioses 16S rdna Sequencing Diagnosis of Spirochetemia in Lyme and related Borrelioses Sin Hang Lee, MD, F.R.C.P.(C)* Pathologist, Milford Hospital and Director, Milford Medical Laboratory, Inc. Milford, CT Email:

More information

Page 1 of 6 Interim Guidance for Emergency Medical Services (EMS) Systems and 9-1-1 Public Safety Answering Points (PSAPs) for Management of Patients Who Present With Possible Ebola Virus Disease in the

More information

COMMUNITY SERVICE WORKER 1 and 2 -Bilingual

COMMUNITY SERVICE WORKER 1 and 2 -Bilingual B001B B002B Established 01/30/91 Updated 03/11/02 Updated 09/14/06 Updated 11/18/09 DEFINITION COMMUNITY SERVICE WORKER 1 and 2 -Bilingual To provide a variety of services to the community and to assist

More information

Diagnostic Preparedness Platform WHO R&D Blueprint for Priority Infectious Diseases with Epidemic Potential

Diagnostic Preparedness Platform WHO R&D Blueprint for Priority Infectious Diseases with Epidemic Potential Diagnostic Preparedness Platform WHO R&D Blueprint for Priority Infectious Diseases with Epidemic Potential 2 nd round presentation Geneva July 21 st, 2016 Diagnostic Preparedness Platform Aim Surveillance

More information

College of Physicians and Surgeons of Saskatchewan Laboratory Quality Assurance Program. Policy Manual Edition

College of Physicians and Surgeons of Saskatchewan Laboratory Quality Assurance Program. Policy Manual Edition College of Physicians and Surgeons of Saskatchewan Laboratory Quality Assurance Program Policy Manual 2016 Edition LABORATORY QUALITY ASSURANCE POLICY MANUAL SUMMARY OF POLICY MANUAL CHANGES The following

More information

Section I: Pharmaceuticals and Medical Devices

Section I: Pharmaceuticals and Medical Devices SUPPLEMENT on HEALTHCARE INNOVATION Visionary Goals and Recommendations 51th Japan-U.S. Business Conference Japan-U.S. Business Council / U.S.-Japan Business Council November 14, 2014 The R&D-based pharmaceutical

More information

Getting a Grip on Lab Outreach Financial Management

Getting a Grip on Lab Outreach Financial Management Getting a Grip on Lab Outreach Financial Management Presented by: Barry Portugal Tom Hirsch Dennis Padget Washington G-2 Reports Audio Conference April 21, 2005 1 Conference Objectives Present overview

More information

Inactivating Zaire Ebolavirus in Whole Blood Thin Smears used for Malaria. Diagnosis

Inactivating Zaire Ebolavirus in Whole Blood Thin Smears used for Malaria. Diagnosis JCM Accepted Manuscript Posted Online 10 February 2016 J. Clin. Microbiol. doi:10.1128/jcm.02960-15 Copyright 2016, American Society for Microbiology. All Rights Reserved. 1 2 3 4 5 6 7 8 9 10 11 12 13

More information

August 2017 Changes. Flow Cytometry Checklist. CAP Accreditation Program

August 2017 Changes. Flow Cytometry Checklist. CAP Accreditation Program August 2017 Changes Flow Cytometry Checklist CAP Accreditation Program College of American Pathologists 325 Waukegan Road Northfield, IL 60093-2750 www.cap.org 08.21.2017 Disclaimer and Copyright Notice

More information

Training Bulletin. Emergency Health Services Branch Ministry of Health and Long-Term Care. October 24, Issue Number version 2.

Training Bulletin. Emergency Health Services Branch Ministry of Health and Long-Term Care. October 24, Issue Number version 2. Training Bulletin Ebola Virus Disease October 24, 2014 Issue Number 114 - version 2.1 Emergency Health Services Branch Ministry of Health and Long-Term Care Training Bulletin, Issue Number 114 version

More information

PPPS IN THE SOCIAL SECTORS: EDUCATION AND HEALTH

PPPS IN THE SOCIAL SECTORS: EDUCATION AND HEALTH PPPS IN THE SOCIAL SECTORS: EDUCATION AND HEALTH JACQUES COOK PUBLIC-PRIVATE PARTNERSHIP WHITE PAPER SERIES Introduction Public-Private Partnerships (PPPs) have been successfully applied in many countries

More information

Aligning Lab Goals & Institutional Goals Laughlin Rice

Aligning Lab Goals & Institutional Goals Laughlin Rice Aligning Lab Goals & Institutional Goals Laughlin Rice Senior Administrative Director Department of Pathology & Laboratory Medicine The Children s Hospital of Learning Objectives To understand the institutional

More information

Getting Started the basics of organizing a strategic sourcing program

Getting Started the basics of organizing a strategic sourcing program Getting Started the basics of organizing a strategic sourcing program SM Copyright 2005 United Parcel Service of America, Inc. All Rights Reserved. No part of this publication may be reproduced without

More information

Global Health Technologies Invention saving lives

Global Health Technologies Invention saving lives Global Health Technologies Invention saving lives Applying the unique advantages of Global Good and Intellectual Ventures Lab to eliminate disease and improve healthcare outcomes Photo credit: Alexander

More information

Molecular Diagnostics

Molecular Diagnostics Molecular Diagnostics Part II: Regulations, Markets & Companies By Prof. K. K. Jain MD, FRACS, FFPM Jain PharmaBiotech Basel, Switzerland May 2018 A Jain PharmaBiotech Report A U T H O R ' S B I O G R

More information

Deployment of a full clinical laboratory capability to support enhanced clinical care in an Ebola treatment unit in Sierra Leone

Deployment of a full clinical laboratory capability to support enhanced clinical care in an Ebola treatment unit in Sierra Leone Clinical Microbiology and Infectious Diseases Research Article ISSN: 2398-8096 Deployment of a full clinical laboratory capability to support enhanced clinical care in an Ebola treatment unit in Sierra

More information

SAMPLE PROCEDURE , 11/07

SAMPLE PROCEDURE , 11/07 SAMPLE PROCEDURE This Sample Procedure is not intended as a substitute for your facility s Procedure Manual or reagent labeling, but rather as a model for your use in customizing for your laboratory s

More information

Procedures for Identifying Pathogens and Diagnosing Infection

Procedures for Identifying Pathogens and Diagnosing Infection Chapter 17 Procedures for Identifying Pathogens and Diagnosing Infection 1 Copyright The McGraw-Hill Companies, Inc. Permission required for reproduction or display. 17.1 An Overview of Clinical Microbiology

More information

Presented by: Tess L. Crisostomo Laboratory Quality Assurance/Compliance Officer Naval Medical Center San Diego

Presented by: Tess L. Crisostomo Laboratory Quality Assurance/Compliance Officer Naval Medical Center San Diego Presented by: Tess L. Crisostomo Laboratory Quality Assurance/Compliance Officer Naval Medical Center San Diego Discuss the difference between DNA Genotyping and Genome Sequencing What makes you who you

More information

SPECIFIC DEPARTMENT INSTRUCTIONS:

SPECIFIC DEPARTMENT INSTRUCTIONS: Subject LIS Downtime Instructions - Regional Clinic / Affiliate Hospital Laboratories Index Number Lab-1520 Section Laboratory Subsection Regional Clinic / Affiliate Hospital Laboratories Category Departmental

More information

CSR STRATEGY, GOVERNANCE & MATERIALITY

CSR STRATEGY, GOVERNANCE & MATERIALITY Stakeholder Importance (External) CSR STRATEGY, GOVERNANCE & MATERIALITY G4 indicators: G4-18, G4-19, G4-20, G4-21, G4-24, G4-27, G4-56 CSR STRATEGY Our Corporate Social Responsibility (CSR) strategy is

More information

arxiv: v4 [q-bio.pe] 2 Sep 2014

arxiv: v4 [q-bio.pe] 2 Sep 2014 Pre-print version of manuscript published at PLOS Currents Outbreaks (2 September 2014) Estimating the reproduction number of Ebola virus (EBOV) during the 2014 outbreak in West Africa Christian L. Althaus

More information

Daniel J. Mollura, MD Tara N. Palmore, MD Les R. Folio, DO David A. Bluemke, MD, PhD. Original Research n Special Report

Daniel J. Mollura, MD Tara N. Palmore, MD Les R. Folio, DO David A. Bluemke, MD, PhD. Original Research n Special Report Note: This copy is for your personal non-commercial use only. To order presentation-ready copies for distribution to your colleagues or clients, contact us at www.rsna.org/rsnarights. Original Research

More information

Serological Testing: Why we did what we did!

Serological Testing: Why we did what we did! Serological Testing: Why we did what we did! W. John Judd, FIBMS, MIBiol Emeritus Professor University of Michigan What we did Provided blood and blood products in a timely, cost-efficient manner. Implemented

More information

WHO STRATEGIC RESPONSE PLAN. West Africa Ebola Outbreak

WHO STRATEGIC RESPONSE PLAN. West Africa Ebola Outbreak 2015 WHO STRATEGIC RESPONSE PLAN West Africa Ebola Outbreak WHO Library Cataloguing-in-Publication Data 2015 WHO Strategic Response Plan: West Africa Ebola Outbreak I.World Health Organization. ISBN 978

More information

PROJECT FACILITY ACCESSIBLE FINANCE FOR RENEWABLE ENERGY IN DEVELOPING COUNTRIES. Photograph: AMADER

PROJECT FACILITY ACCESSIBLE FINANCE FOR RENEWABLE ENERGY IN DEVELOPING COUNTRIES. Photograph: AMADER PROJECT FACILITY ACCESSIBLE FINANCE FOR RENEWABLE ENERGY IN DEVELOPING COUNTRIES Photograph: AMADER JANUARY 2018 To date, the Facility has mobilised over USD 630 million for 21 renewable energy projects

More information

Morris Animal. FOUNDATION Golden Retriever Lifetime Study

Morris Animal. FOUNDATION Golden Retriever Lifetime Study Morris Animal FOUNDATION Golden Retriever Lifetime Study Golden Retreiver Lifetime Study Annual Veterinary Sample Kit: Collection & Shipping Instructions Tips for Participating Veterinarians Thank you

More information

Core Competencies for Public Health Professionals

Core Competencies for Public Health Professionals Switch Gears Competency Development: Council on Linkages Between Academia and Public Health Practice Competency Development Process Public Comment Lessons Learned What else is out there Who s Next? Actually

More information

Michigan Integrated Food and Farming Systems 2005 Marketing & Communications Plan

Michigan Integrated Food and Farming Systems 2005 Marketing & Communications Plan Michigan Integrated Food and Farming Systems 2005 Marketing & Communications Plan Table of Contents 1. MIFFS Organization Background Vision Purpose Principles 2. MIFFS Marketing Communications Objectives

More information

What it takes to make a new state of the art diagnostics platform for Point of Care use.

What it takes to make a new state of the art diagnostics platform for Point of Care use. What it takes to make a new state of the art diagnostics platform for Point of Care use. 31.10.2006 Axis-Shield plc 450 employees Turnover 58 million Profit before tax 1,9 million R&D spend 7,4 million

More information

The MSO (Management Services Organization) Concept

The MSO (Management Services Organization) Concept The MSO (Management Services Organization) Concept August 2010 Presented By: Ken Welch, Hawaiian HealthCare Consultant MSO, A Definition A Management Services Organization is an organization that can provide

More information

Global Molecular Diagnostics Market Report

Global Molecular Diagnostics Market Report Global Molecular Diagnostics Market Report ----------------------------------------- 2014 Executive Summary Over the years, medical science has made unprecedented progress in almost every sphere of human

More information

Brand Plan Sample Template. Akademia Marketingu Farmaceutycznego

Brand Plan Sample Template. Akademia Marketingu Farmaceutycznego Brand Plan Sample Template Akademia Marketingu Farmaceutycznego Key Marketing Questions 1. 1 What is the basic definition of your market? 2. 2 Who are your target audiences in the marketplace? 3. 3 What

More information